BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

InfaCare Names John R. Post President And CEO


10/19/2005 5:12:26 PM

NEPTUNE, N.J., Dec. 13 /PRNewswire/ -- InfaCare Pharmaceutical Corporation announced today that John R. Post has been appointed President and Chief Executive Officer of the Company. InfaCare is a specialty pharmaceutical company focused on developing innovative therapies for neonates and older children. The company is based in Neptune, NJ.

"The Board of Directors is extremely pleased with this appointment," said Dr. Vukovich, InfaCare's founder and Chairman. "John's general management, marketing and sales background provides an ideal blend of operational experience which will allow him to provide the strategic leadership InfaCare now requires. Over his 29-year career in the industry, John has acquired extensive experience in the area of new products, from providing commercial perspective in early drug development to preparing and executing new product launches. We are delighted at John's decision to join InfaCare and look forward to his leadership at an important time in the company's development."

InfaCare Pharmaceutical Corporation is a privately held pharmaceutical company founded in 2001 by Dr. Robert A. Vukovich. The company is currently developing Stanate(R) for the treatment of hyperbilirubinemia (elevated bilirubin levels leading to jaundice and possible neurological damage) in neonates. Commenting on his new assignment, Mr. Post said, "I look forward to building and leading the organization as it pursues the regulatory approval of Stanate(R)."

John's entire career has been spent in the pharmaceutical industry where he successfully served the interests of Pfizer Inc. and Boehringer Ingelheim Pharmaceuticals Inc. Prior to his appointment as Chief Operating Officer of InfaCare in June 2004, John served the interests of Pfizer as Area President, Europe/Africa/Middle East/Canada for their Animal Health Division. Other positions held at Pfizer include Vice President, Marketing; Vice President, US Livestock Division; General Manager, Canadian Operations, as well as a variety of sales and marketing positions within the human pharmaceutical division. While at Boehringer Ingelheim, John served in a variety of senior marketing positions, ultimately heading up the US human health marketing operation. Mr. Post received his BA in Zoology from the University of Santa Barbara.

Contact: Nancy Bracken Tel: (732) 938-5885 Fax: (732) 751-9056 Website: http://www.infacarepharm.com/

InfaCare Pharmaceutical Corporation

CONTACT: Nancy Bracken of InfaCare Pharmaceutical Corporation,+1-732-938-5885, or fax, +1-732-751-9056



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES